Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China flag China · Delayed Price · Currency is CNY
26.03
+1.02 (4.08%)
Apr 30, 2026, 12:54 PM CST

Hubei Goto Biopharm Statistics

Total Valuation

SHE:300966 has a market cap or net worth of CNY 2.88 billion. The enterprise value is 4.17 billion.

Market Cap 2.88B
Enterprise Value 4.17B

Important Dates

The last earnings date was Wednesday, April 29, 2026.

Earnings Date Apr 29, 2026
Ex-Dividend Date n/a

Share Statistics

SHE:300966 has 115.08 million shares outstanding. The number of shares has decreased by -0.30% in one year.

Current Share Class 115.08M
Shares Outstanding 115.08M
Shares Change (YoY) -0.30%
Shares Change (QoQ) -10.84%
Owned by Insiders (%) 44.74%
Owned by Institutions (%) 3.88%
Float 54.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.75
PB Ratio 3.17
P/TBV Ratio 3.73
P/FCF Ratio n/a
P/OCF Ratio 70.14
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 51.01, with an EV/FCF ratio of -33.32.

EV / Earnings -56.91
EV / Sales 6.89
EV / EBITDA 51.01
EV / EBIT n/a
EV / FCF -33.32

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 1.43.

Current Ratio 0.94
Quick Ratio 0.34
Debt / Equity 1.43
Debt / EBITDA 15.88
Debt / FCF -10.37
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -8.50% and return on invested capital (ROIC) is -1.58%.

Return on Equity (ROE) -8.50%
Return on Assets (ROA) -0.74%
Return on Invested Capital (ROIC) -1.58%
Return on Capital Employed (ROCE) -1.66%
Weighted Average Cost of Capital (WACC) 3.89%
Revenue Per Employee 741,956
Profits Per Employee -89,791
Employee Count 817
Asset Turnover 0.21
Inventory Turnover 1.22

Taxes

Income Tax -23.49M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +62.09% in the last 52 weeks. The beta is 0.25, so SHE:300966's price volatility has been lower than the market average.

Beta (5Y) 0.25
52-Week Price Change +62.09%
50-Day Moving Average 21.29
200-Day Moving Average 21.51
Relative Strength Index (RSI) 76.79
Average Volume (20 Days) 3,401,431

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHE:300966 had revenue of CNY 606.18 million and -73.36 million in losses. Loss per share was -0.64.

Revenue 606.18M
Gross Profit 83.50M
Operating Income -33.58M
Pretax Income -105.21M
Net Income -73.36M
EBITDA 81.78M
EBIT -33.58M
Loss Per Share -0.64
Full Income Statement

Balance Sheet

The company has 85.85 million in cash and 1.30 billion in debt, giving a net cash position of -1.21 billion or -10.54 per share.

Cash & Cash Equivalents 85.85M
Total Debt 1.30B
Net Cash -1.21B
Net Cash Per Share -10.54
Equity (Book Value) 909.36M
Book Value Per Share 7.44
Working Capital -51.79M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 41.04 million and capital expenditures -166.33 million, giving a free cash flow of -125.29 million.

Operating Cash Flow 41.04M
Capital Expenditures -166.33M
Depreciation & Amortization 115.36M
Net Borrowing 142.32M
Free Cash Flow -125.29M
FCF Per Share -1.09
Full Cash Flow Statement

Margins

Gross margin is 13.77%, with operating and profit margins of -5.54% and -12.10%.

Gross Margin 13.77%
Operating Margin -5.54%
Pretax Margin -17.36%
Profit Margin -12.10%
EBITDA Margin 13.49%
EBIT Margin -5.54%
FCF Margin n/a

Dividends & Yields

SHE:300966 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.30%
Shareholder Yield 0.30%
Earnings Yield -2.55%
FCF Yield -4.35%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2